Alpha-lipoic acid for diabetic peripheral neuropathy

  • Protocol
  • Intervention

Authors

  • Nasir Mirza,

    Corresponding author
    1. National Hospital for Neurology and Neurosurgery, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, London, UK
    • Nasir Mirza, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, PO Box 114, Queen Square, London, WC1N 3BG, UK. nasir.mirza@doctors.org.uk.

    Search for more papers by this author
  • David R Cornblath,

    1. Johns Hopkins Hospital, Department of Neurology, Baltimore, Maryland, USA
    Search for more papers by this author
  • Syed Hasan,

    1. National Hospital for Neurology and Neurosurgery, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, London, UK
    Search for more papers by this author
  • Usman Hussain

    1. National Hospital for Neurology and Neurosurgery, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, London, UK
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of alpha-lipoic acid on symptoms, impairment and neurophysiological attributes in established diabetic peripheral neuropathy.

Ancillary